186 related articles for article (PubMed ID: 11932086)
21. Evaluation of major depressive disorder in patients receiving chronic treatment with topical timolol.
Bali SJ; Parmar T; Arora V; Ichhpujani P; Sagar R; Dada T
Ophthalmologica; 2011; 226(3):157-60. PubMed ID: 21832816
[TBL] [Abstract][Full Text] [Related]
22. Sinoatrial block induced by timolol eyedrops.
Calenda E; Tourrel F
Can J Ophthalmol; 2007 Feb; 42(1):149. PubMed ID: 17361266
[No Abstract] [Full Text] [Related]
23. Cardiovascular considerations in using topical, oral, and intravenous drugs for the treatment of glaucoma and ocular hypertension: focus on beta-adrenergic blockade.
Frishman WH; Kowalski M; Nagnur S; Warshafsky S; Sica D
Heart Dis; 2001; 3(6):386-97. PubMed ID: 11975823
[TBL] [Abstract][Full Text] [Related]
24. Third degree AC block due to ophthalmic timilol solution.
Sharifi M; Koch JM; Steele RJ; Adler D; Pompili VJ; Sopko J
Int J Cardiol; 2001; 80(2-3):257-9. PubMed ID: 11676388
[No Abstract] [Full Text] [Related]
25. Topical timolol for treatment of epistaxis in hereditary haemorrhagic telangiectasia associated with bradycardia: a look at CYP2D6 metabolising variants.
Epperla N; Brilliant MH; Vidaillet H
BMJ Case Rep; 2014 Feb; 2014():. PubMed ID: 24518395
[TBL] [Abstract][Full Text] [Related]
26. Cytochrome oxidase 2D6 gene polymorphism in primary open-angle glaucoma with various effects to ophthalmic timolol.
Yang Y; Wu K; Yuan H; Yu M
J Ocul Pharmacol Ther; 2009 Apr; 25(2):163-71. PubMed ID: 19284319
[TBL] [Abstract][Full Text] [Related]
27. Neuropsychiatric Adverse Events from Topical Ophthalmic Timolol.
Cimolai N
Clin Med Res; 2019 Dec; 17(3-4):90-96. PubMed ID: 31462538
[TBL] [Abstract][Full Text] [Related]
28. Serum lipid profile and timolol gel.
Khamar MB; Bhatt N; Patel K
J Indian Med Assoc; 2002 Oct; 100(10):620-1. PubMed ID: 12452518
[TBL] [Abstract][Full Text] [Related]
29. [Atrioventricular block secondary to topical ophthalmic beta blockers].
Rubín López JM; Hevía Nava S; Veganzones Bayón A; Barriales Alvarez V
Rev Esp Cardiol; 1999 Jul; 52(7):532. PubMed ID: 10439680
[TBL] [Abstract][Full Text] [Related]
30. Association of CYP2D6 single-nucleotide polymorphism with response to ophthalmic timolol in primary open-angle Glaucoma--a pilot study.
Yuan H; Yu M; Yang Y; Wu K; Lin X; Li J
J Ocul Pharmacol Ther; 2010 Oct; 26(5):497-501. PubMed ID: 20925579
[TBL] [Abstract][Full Text] [Related]
31. Bradycardia induced by interaction between quinidine and ophthalmic timolol.
Dinai Y; Sharir M; Naveh N; Halkin H
Ann Intern Med; 1985 Dec; 103(6 ( Pt 1)):890-1. PubMed ID: 4062090
[No Abstract] [Full Text] [Related]
32. The safety of topical beta-blockers in glaucoma treatment.
Goldberg I
Med J Aust; 1996 Apr; 164(8):498-9. PubMed ID: 8614346
[TBL] [Abstract][Full Text] [Related]
33. [Adverse effects of local use of beta-blockaders in glaucoma. A literature review and a survey of reports to the adverse drug reaction authority 1986-95].
Nygaard HA; Høvding G
Tidsskr Nor Laegeforen; 1997 May; 117(14):2019-21. PubMed ID: 9235677
[TBL] [Abstract][Full Text] [Related]
34. [Timolol topical ophthalmic combination].
Călugăru M; Călugăru D
Oftalmologia; 2004; 48(1):5-14. PubMed ID: 15279411
[TBL] [Abstract][Full Text] [Related]
35. Timolol drops causing reversible psoriatic fingernail changes.
Glass LR; Nguyen M; Winn BJ; Schrier A
JAMA Ophthalmol; 2013 Sep; 131(9):1134. PubMed ID: 24030331
[No Abstract] [Full Text] [Related]
36. A double-masked randomized comparison of the efficacy and safety of unoprostone with timolol and betaxolol in patients with primary open-angle glaucoma including pseudoexfoliation glaucoma or ocular hypertension. 6 month data.
Nordmann JP; Mertz B; Yannoulis NC; Schwenninger C; Kapik B; Shams N;
Am J Ophthalmol; 2002 Jan; 133(1):1-10. PubMed ID: 11755834
[TBL] [Abstract][Full Text] [Related]
37. Allergic contact dermatitis caused by timolol eyedrop application for infantile haemangioma.
Sacchelli L; Vincenzi C; La Placa M; Piraccini BM; Neri I
Contact Dermatitis; 2019 Apr; 80(4):255-256. PubMed ID: 30485454
[No Abstract] [Full Text] [Related]
38. The influence of diclofenac ophthalmic solution on the intraocular pressure-lowering effect of topical 0.5% timolol and 0.005% latanoprost in primary open-angle glaucoma patients.
Costagliola C; Parmeggiani F; Antinozzi PP; Caccavale A; Cotticelli L; Sebastiani A
Exp Eye Res; 2005 Nov; 81(5):610-5. PubMed ID: 15949795
[TBL] [Abstract][Full Text] [Related]
39. Comparison of Two Formulations of Topical Timolol for the Treatment of Infantile Hemangiomas.
Ng MSY; Tay YK; Ng SS; Foong AYW; Koh MJ
Pediatr Dermatol; 2017 Jul; 34(4):492-493. PubMed ID: 28543755
[TBL] [Abstract][Full Text] [Related]
40. Topical timolol maleate might adversely affect serum lipoproteins.
Safran AB; Simona F; Sansonetti A; Pometta D; James R
Int Ophthalmol; 1993 Apr; 17(2):109-10. PubMed ID: 8407117
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
